The Chinese-German Journal of Clinical Oncology

, Volume 5, Issue 6, pp 436–437 | Cite as

Neoadjuvant chemotherapy with pingyangmycin can inhibit the amplification and metastasis of laryngeal squamous cell carcinoma

  • Xiaolong Li
  • Ming Gao
  • Haifeng Yu
  • Benyi Xu
  • Zhengjin Ge
  • Yang Yu
  • Songfeng Wei
  • Shuling Li
Article
  • 17 Downloads

Abstract

Objective

To evaluate the short-term effects of neoadjuvant chemotherapy with pingyangmycin (PYM) in the treatment of laryngeal squamous cell carcinoma.

Methods

24 cases of laryngeal squamous cell carcinoma were treated with PYM before the operation, and the surgeries were undergone within one week after neoadjuvant chemotherapy. PCNA, p53, Bcl-2 and CD44v6 were detected in the specimens of tumor, retreated tumor and normal tissue using immunohistochemical methods.

Results

Apoptosis could be detected more often in specimens with tumor and retreated tumor after chemotherapy than that before. The expression of PCNA, p53, Bcl-2 and CD44v6 in tumor tissue after neoadjuvant chemotherapy with PYM was weaker than that before the chemotherapy. There was significant difference in the positive ratio of PCNA, p53, Bcl-2 and CD44v6 between retreated tumor and tumor.

Conclusion

After neoadjuvant chemotherapy with PYM, a large number of tumor cells died. The amplification and metastasis of tumor were suppressed by neoadjuvant chemotherapy with PYM.

Key words

laryngeal squamous cell carcinoma PYM neoadjuvant chemotherapy PCNA p53 Bcl-2 CD44v6 

References

  1. 1.
    Suarez C, Rodrigo JP, Herranz J, et al. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol, 1995, 104: 358–363.PubMedGoogle Scholar
  2. 2.
    The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med, 1991, 324: 1685–1690.CrossRefGoogle Scholar
  3. 3.
    Lore JM Jr, Diaz-Ordaz E, Spaulding M, et al. Improved survival with preoperative chemotherapy followed by resection uncompromised by tumor response for advanced squamous cell carcinoma of the head and neck. Am J Surg, 1995, 170: 506–511.PubMedCrossRefGoogle Scholar
  4. 4.
    Urano M, Iwata S, Takasu A, et al. An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords. Nippon Jibiinkoka Gakkai Kaiho (Japanese), 1996, 99: 395–401.Google Scholar
  5. 5.
    Fang JG, Liang EH, Liu CY, et al. Study of apoptosis and DNA statues in head and neck carcinoma with preoperative chemotherapy. Chinese Arch Otolaryngol Head Neck Srug (Chinese), 1999, 6: 95–98.Google Scholar
  6. 6.
    Yuen AP, Lam KY, Choy JT, et al. The clinicopathological significance of bcl-2 expression in the surgical treatment of laryngeal carcinoma. Clin Otolaryngol Allied Sci, 2001, 26: 129–133.PubMedCrossRefGoogle Scholar
  7. 7.
    Spafford MF, Koeppe J, Pan Z, et al. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 1996, 122: 627–632.PubMedGoogle Scholar

Copyright information

© Editorial Office of the Chinese-German Journal of Clinical Oncology 2006

Authors and Affiliations

  • Xiaolong Li
    • 1
  • Ming Gao
    • 1
  • Haifeng Yu
    • 1
  • Benyi Xu
    • 1
  • Zhengjin Ge
    • 1
  • Yang Yu
    • 1
  • Songfeng Wei
    • 1
  • Shuling Li
    • 1
  1. 1.Department of Head & Neck 2Tianjin Medical University Cancer HospitalTianjinChina

Personalised recommendations